about
Common genetic variation and the control of HIV-1 in humansGenome-wide association study identifies single nucleotide polymorphism in DYRK1A associated with replication of HIV-1 in monocyte-derived macrophagesWGAViewer: software for genomic annotation of whole genome association studiesThe Duffy antigen receptor for chemokines null promoter variant does not influence HIV-1 acquisition or disease progressionPrivacy in the Genomic EraGenetic variation in IL28B predicts hepatitis C treatment-induced viral clearanceInterleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virusGenomewide association study for determinants of HIV-1 acquisition and viral set point in HIV-1 serodiscordant couples with quantified virus exposureHost determinants of HIV-1 control in African Americans.Common human genetic variants and HIV-1 susceptibility: a genome-wide survey in a homogeneous African population.GuavaH: a compendium of host genomic data in HIV biology and disease.Genome-wide association study of interferon-related cytopenia in chronic hepatitis C patients.Genome-wide mRNA expression correlates of viral control in CD4+ T-cells from HIV-1-infected individualsCo-trimoxazole prophylaxis is associated with reduced risk of incident tuberculosis in participants in the Swiss HIV Cohort Study.The characterization of twenty sequenced human genomes.Host genetics and HIV-1: the final phase?Host genetics influences on HIV type-1 disease.Viral genetic variation accounts for a third of variability in HIV-1 set-point viral load in Europe.Role of human leukocyte antigen class I alleles in progressive multifocal leukoencephalopathy.HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C.Analysis of stop-gain and frameshift variants in human innate immunity genes.Counteraction of HLA-C-mediated immune control of HIV-1 by Nef.Copy number variation of KIR genes influences HIV-1 control.IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genes in patients with chronic hepatitis C.Disentangling human tolerance and resistance against HIV.Evidence of dysregulation of dendritic cells in primary HIV infection.HLA class I and KIR genes do not protect against HIV type 1 infection in highly exposed uninfected individuals with hemophilia A.A novel Acute Retroviral Syndrome Severity Score predicts the key surrogate markers for HIV-1 disease progression.Host genetic determinants of T cell responses to the MRKAd5 HIV-1 gag/pol/nef vaccine in the step trial.Variants in the ITPA gene protect against ribavirin-induced hemolytic anemia and decrease the need for ribavirin dose reductionAssociation study of common genetic variants and HIV-1 acquisition in 6,300 infected cases and 7,200 controls.Comparative transcriptomics of extreme phenotypes of human HIV-1 infection and SIV infection in sooty mangabey and rhesus macaque.Estimating the net contribution of interleukin-28B variation to spontaneous hepatitis C virus clearance.LILRB2 interaction with HLA class I correlates with control of HIV-1 infection.Dynamics of HIV latency and reactivation in a primary CD4+ T cell model.A polymorphism in the leptin gene promoter is associated with anemia in patients with HIV diseaseMapping of positive selection sites in the HIV-1 genome in the context of RNA and protein structural constraints.Role of retroviral restriction factors in the interferon-α-mediated suppression of HIV-1 in vivo.The Characteristics of Heterozygous Protein Truncating Variants in the Human Genome.Pharmacogenomics of HIV therapy: summary of a workshop sponsored by the National Institute of Allergy and Infectious Diseases.
P50
Q21092450-F9D15AD1-5BB4-4102-9993-42C79E4C5BBAQ21135536-C7A350FF-8246-47F3-92D9-733DD0327E85Q24646837-AD91AAB8-6DDA-4599-8040-EE62BF7477C9Q24657521-961CA4D8-BC23-44AF-8BF5-21B25C913C89Q27316478-E4B5B6A1-F659-492D-A772-CB83C846A224Q28255243-8831C7B3-3F52-4C7B-A171-21AE62D877C2Q28279955-E4289DE6-515F-4B63-AA58-8A8707B0C212Q29417004-B4962D3C-FF41-4298-8F4E-6D48133CE05CQ29417075-43FEADBE-268B-41A0-98BF-087F69C41D15Q29417119-6916942D-5F95-4646-AE42-5DD041497E58Q30734355-16D7096E-1B56-419C-9E25-21FB76006046Q33395929-2EBD025E-5536-45B4-97C2-E16EE104FBCEQ33535874-0FD4675C-ABF1-49CF-8944-8FD0381953F2Q33622785-25CEEA03-C366-461B-821C-B9BC5955BE70Q33691366-DBC91A1F-867A-43D2-8096-E46E836ADE45Q33728658-B9755F7D-4CD3-45B0-B5A4-6D849DDCE76FQ33775595-06710335-40C6-459E-B3BD-9C5F7B8E0BA1Q33788085-6FF3760C-F73B-4CA8-AFA1-C13870DFC80AQ33789032-A76C9600-0186-48E2-AFCD-D61167C12E08Q33918894-63E56D78-FD1A-4037-946D-07C9FB6FB95CQ33946297-6D2891A3-F598-466B-B8E0-3A99DDBCCB25Q33966673-DEB45535-F42C-4796-876A-E85E865DDB6CQ34090869-C88BFB42-DE4F-41A8-9010-6F64DBBA313AQ34142463-D149A7FF-542F-4C8A-9058-B56E05D7A0C1Q34195511-638E1D3E-E396-4257-A02D-64729C9A9AE3Q34310896-AB3069F7-2248-4C13-8860-61DBE9AEE51CQ34430254-4763BB14-7E90-4926-9C76-8D231133627DQ34662516-089BAA17-73EF-48C5-BE82-5CE58EFA7AA2Q34764031-C8CA2C3F-BCB0-4288-BDB0-1DE09524B278Q34913385-2756BA43-E0E8-47EB-A20D-3AA005A916D7Q34916745-163F0075-EDDD-4930-9E41-C93097B2EF52Q35015712-4FD392BF-1DA9-455F-9C0F-F85CE5A41EBDQ35083980-82CB8AAD-C310-49BB-8B4B-3DC94118C0DBQ35112707-64B130FE-70AA-43EB-9254-3C8B70563EE4Q35176166-C52A74E6-3D94-4814-9B30-19CFD5639C5CQ35553295-D8A598FA-15FB-4B71-B29D-5490A91821F4Q35589028-4F4A6A16-7258-4AED-9144-EEEBBE97EE24Q35778972-A6FE59CD-489C-4E3A-BBDE-7E4C1EF01CB7Q35862547-5179708A-FFF6-49EB-B7FA-0680530394F7Q35878413-392E03D8-C708-4598-9161-44591432A995
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Jacques Fellay
@ast
Jacques Fellay
@en
Jacques Fellay
@es
Jacques Fellay
@sl
type
label
Jacques Fellay
@ast
Jacques Fellay
@en
Jacques Fellay
@es
Jacques Fellay
@sl
prefLabel
Jacques Fellay
@ast
Jacques Fellay
@en
Jacques Fellay
@es
Jacques Fellay
@sl
P108
P1053
A-6681-2009
P106
P1153
7801474482
P21
P2456
P31
P3829
P496
0000-0002-8240-939X